GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PELL Bio-Med Technology Co Ltd (TPE:6949) » Definitions » Research & Development

PELL Bio-Med Technology Co (TPE:6949) Research & Development : NT$267.57 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is PELL Bio-Med Technology Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. PELL Bio-Med Technology Co's Research & Development for the three months ended in Mar. 2025 was NT$51.34 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was NT$267.57 Mil.


PELL Bio-Med Technology Co Research & Development Historical Data

The historical data trend for PELL Bio-Med Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PELL Bio-Med Technology Co Research & Development Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Research & Development
136.82 142.55 239.61 266.16

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.93 74.74 71.70 69.79 51.34

PELL Bio-Med Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$267.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PELL Bio-Med Technology Co  (TPE:6949) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


PELL Bio-Med Technology Co Research & Development Related Terms

Thank you for viewing the detailed overview of PELL Bio-Med Technology Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


PELL Bio-Med Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell).

PELL Bio-Med Technology Co Headlines

No Headlines